Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$35.27 n/a | n/a%
12/07/16 - 04:01 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 19.65B 20.27B 20.31B 20.32B
Cost of Sales 6.99B 7.71B 7.96B 7.96B
Gross Operating Profit 12.66B 12.56B 12.35B 12.36B
Selling, General, and Administrative Expenses 5.35B 4.97B 6.84B 5.12B
Research & Development 1.52B 1.49B 1.43B 1.36B
Operating Income before D & A (EBITDA) 5.79B 6.11B 4.08B 5.89B
Depreciation & Amortization 1.31B 1.51B 1.64B 1.71B
Interest Income 1.00B 313.00M 399.00M 0.00
Other Income - Net -2.12B -631.00M -838.00M -792.00M
Special Income / Charges -1.13B -650.00M -788.00M -1.26B
Total Income Before Interest Expenses (EBIT) 2.23B 3.63B 1.21B 2.13B
Interest Expense 0.00 0.00 0.00 355.00M
Pre-Tax Income 2.23B 3.63B 1.21B 1.77B
Income Taxes 634.00M 591.00M -43.00M -137.00M
Minority Interest 9.00M -13.00M -16.00M -53.00M
Net Income From Continuing Operations 1.60B 3.04B 1.25B 1.91B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.60B 3.04B 1.25B 1.91B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.59B 3.06B 1.27B 1.96B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.73B 3.69B 2.04B 3.17B
Preferred Dividends
Net Income Available To Common 1.58B 3.04B 1.25B 1.91B
Basic EPS from Continuing Ops. 1.84 3.58 1.49 2.25
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.84 3.58 1.49 2.25
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.84 3.58 1.49 2.25
Basic Normalized Net Income/Share 3.14 4.34 2.43 3.73
EPS fr Continuing Ops. 1.82 3.56 1.49 2.25
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.82 3.56 1.49 2.25
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.82 3.56 1.49 2.25
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.11 4.32 2.43 3.73
Dividends Paid per Share 1.36 1.37 1.28 1.03

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases

Partner Headlines for TEVA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter